{"pmid":32356322,"title":"Special Considerations in the Management of Patients with Myelodysplastic Syndrome / Myeloproliferative Neoplasm Overlap Syndromes During the SARS-CoV-2 Pandemic.","text":["Special Considerations in the Management of Patients with Myelodysplastic Syndrome / Myeloproliferative Neoplasm Overlap Syndromes During the SARS-CoV-2 Pandemic.","Am J Hematol","Patnaik, Mrinal M","Lasho, Terra","Padron, Eric","McCullough, Kristen","Al-Kali, Aref","Tefferi, Ayalew","Zeidan, Amer M","Gangat, Naseema","Savona, Michael","Steensma, David P","Solary, Eric","32356322"],"journal":"Am J Hematol","authors":["Patnaik, Mrinal M","Lasho, Terra","Padron, Eric","McCullough, Kristen","Al-Kali, Aref","Tefferi, Ayalew","Zeidan, Amer M","Gangat, Naseema","Savona, Michael","Steensma, David P","Solary, Eric"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32356322","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/ajh.25853","topics":["Prevention"],"weight":1,"_version_":1666138495248236544,"score":9.490897,"similar":[{"pmid":32296994,"pmcid":"PMC7158753","title":"The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments.","text":["The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments.","Eur J Epidemiol","Gonzalez-Jaramillo, Nathalia","Low, Nicola","Franco, Oscar H","32296994"],"journal":"Eur J Epidemiol","authors":["Gonzalez-Jaramillo, Nathalia","Low, Nicola","Franco, Oscar H"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32296994","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s10654-020-00628-1","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138493315710976,"score":52.728085},{"pmid":32343444,"title":"Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic.","text":["Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic.","Elderly patients with head and neck cancer are at increased risk of adverse outcomes during and after treatment of head and neck cancer. COVID-19 severity and mortality can be expected to be significantly greater in elderly patients with head and neck cancer, given that increased age, comorbidities, and presence of malignancy are known risk factors for disease severity and mortality in patients with COVID-19. Therefore, their management requires multidisciplinary consensus and patient input. A thorough geriatric assessment, which has been shown to be beneficial prior to the COVID-19 pandemic, could be particularly helpful in this patient population with the added dimension of COVID-19 risk. In many cases, prudent treatment plan modification may allow for overall best outcomes. Furthermore, recruitment of social services and, when appropriate, palliative care, may allow for optimal management of these patients.","Head Neck","Sharma, Arun","Crosby, Dana L","32343444"],"abstract":["Elderly patients with head and neck cancer are at increased risk of adverse outcomes during and after treatment of head and neck cancer. COVID-19 severity and mortality can be expected to be significantly greater in elderly patients with head and neck cancer, given that increased age, comorbidities, and presence of malignancy are known risk factors for disease severity and mortality in patients with COVID-19. Therefore, their management requires multidisciplinary consensus and patient input. A thorough geriatric assessment, which has been shown to be beneficial prior to the COVID-19 pandemic, could be particularly helpful in this patient population with the added dimension of COVID-19 risk. In many cases, prudent treatment plan modification may allow for overall best outcomes. Furthermore, recruitment of social services and, when appropriate, palliative care, may allow for optimal management of these patients."],"journal":"Head Neck","authors":["Sharma, Arun","Crosby, Dana L"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32343444","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/hed.26216","keywords":["covid-19","sars-cov-2","geriatrics","head and neck cancer","novel coronavirus"],"topics":["Prevention"],"weight":1,"_version_":1666138495106678784,"score":49.129295},{"pmid":32487513,"pmcid":"PMC7258803","title":"Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis.","text":["Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis.","During the ongoing COVID-19 pandemic due to the SARS-CoV-2 virus of which evidence-based medical paradigms cannot be easily applied; difficult clinical decisions shall be required particularly in the 'difficult-to-treat' cases of high risk group with associated comorbidities. Convalescent immune plasma therapy is a promising option as a sort of 'rescue' treatment in COVID-19 immune syndrome, where miraculous antiviral drugs are not available yet. In this report, we aim to convey our experience of multi-task treatment approach with convalescent immune plasma and anti-cytokine drug combination in a COVID-19 patient with extremely challenging comorbidities including active myeloid malignancy, disseminated tuberculosis and kidney failure.","Transfus Apher Sci","Cinar, Olgu Erkin","Sayinalp, Basak","Aladag Karakulak, Elifcan","Avsar Karatas, Ayse","Velet, Mustafa","Inkaya, Ahmet Cagkan","Ersoy Ortac, Nazmiye Ebru","Ocal, Serpil","Aksu, Salih","Haznedaroglu, Ibrahim Celalettin","Sayinalp, Nilgun","Ozcebe, Osman Ilhami","32487513"],"abstract":["During the ongoing COVID-19 pandemic due to the SARS-CoV-2 virus of which evidence-based medical paradigms cannot be easily applied; difficult clinical decisions shall be required particularly in the 'difficult-to-treat' cases of high risk group with associated comorbidities. Convalescent immune plasma therapy is a promising option as a sort of 'rescue' treatment in COVID-19 immune syndrome, where miraculous antiviral drugs are not available yet. In this report, we aim to convey our experience of multi-task treatment approach with convalescent immune plasma and anti-cytokine drug combination in a COVID-19 patient with extremely challenging comorbidities including active myeloid malignancy, disseminated tuberculosis and kidney failure."],"journal":"Transfus Apher Sci","authors":["Cinar, Olgu Erkin","Sayinalp, Basak","Aladag Karakulak, Elifcan","Avsar Karatas, Ayse","Velet, Mustafa","Inkaya, Ahmet Cagkan","Ersoy Ortac, Nazmiye Ebru","Ocal, Serpil","Aksu, Salih","Haznedaroglu, Ibrahim Celalettin","Sayinalp, Nilgun","Ozcebe, Osman Ilhami"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32487513","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.transci.2020.102821","keywords":["covid-19","convalescent","myelodysplastic","plasmapheresis","tuberculosis"],"topics":["Treatment"],"weight":1,"_version_":1668892169360900096,"score":48.348404},{"pmid":32368799,"title":"Utility of Tracheostomy in Patients with COVID-19 and Other Special Considerations.","text":["Utility of Tracheostomy in Patients with COVID-19 and Other Special Considerations.","Patients who become severely ill from COVID-19 have a high likelihood of needing prolonged intubation, making tracheostomy a likely consideration. The infectious nature of COVID-19 poses an additional risk of transmission to healthcare workers that should be taken into consideration. We explore current literature and recommendations for tracheostomy in patients with COVID-19, and look back at previous data from SARS-CoV-1, the virus responsible for the SARS outbreak of 2003. Given the severity and clinical uncertainty of patients with COVID-19 and the increased risk of transmission to clinicians, careful consideration should be taken prior to performing tracheostomy. If tracheostomy is performed, we recommend a bedside approach to limit exposure time and number of exposed personnel. Bronchoscopy use with a percutaneous approach should be limited in order to decrease viral exposure. Thorough preprocedural planning, use of experienced personnel, enhanced PPE where available, and a thoughtful anesthesia approach are instrumental in maximizing positive patient outcomes while successfully protecting the safety of healthcare personnel. This article is protected by copyright. All rights reserved.","Laryngoscope","Mecham, Jeffrey C","Thomas, Olivia J","Pirgousis, Phillip","Janus, Jeffrey R","32368799"],"abstract":["Patients who become severely ill from COVID-19 have a high likelihood of needing prolonged intubation, making tracheostomy a likely consideration. The infectious nature of COVID-19 poses an additional risk of transmission to healthcare workers that should be taken into consideration. We explore current literature and recommendations for tracheostomy in patients with COVID-19, and look back at previous data from SARS-CoV-1, the virus responsible for the SARS outbreak of 2003. Given the severity and clinical uncertainty of patients with COVID-19 and the increased risk of transmission to clinicians, careful consideration should be taken prior to performing tracheostomy. If tracheostomy is performed, we recommend a bedside approach to limit exposure time and number of exposed personnel. Bronchoscopy use with a percutaneous approach should be limited in order to decrease viral exposure. Thorough preprocedural planning, use of experienced personnel, enhanced PPE where available, and a thoughtful anesthesia approach are instrumental in maximizing positive patient outcomes while successfully protecting the safety of healthcare personnel. This article is protected by copyright. All rights reserved."],"journal":"Laryngoscope","authors":["Mecham, Jeffrey C","Thomas, Olivia J","Pirgousis, Phillip","Janus, Jeffrey R"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32368799","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/lary.28734","keywords":["bedside tracheostomy","covid-19","open tracheostomy","percutaneous tracheostomy"],"topics":["Prevention"],"weight":1,"_version_":1666138496187760640,"score":43.95221}]}